So, what is modum? Luckily for me, there’s a little video here which is a great showcase for the tech and what it does. Briefly, Modum is a supply-chain monitor for the pharmaceutical sector that enables companies to comply with legislation from the EU regarding the delivery of medicinal products. Modum’s tech is a passive monitoring device that sits in with shipments to monitor the temperature. During the shipping the temperature is monitored, and when received by the customer, the data is reported back to the blockchain and is publically viewable to the distributor, and the customer. Currently some drug companies are shipping in temperature-controlled containers which are expensive, or use other data-logging devices like used in food distribution, which is unnecessary.
According to Modum’s whitepaper there are over 200 million shipments a year in the EU which would need to be monitored to comply with EU law, and if Modum can capture just a fraction of that market, it’s big money. Modum believes cost-per-shipment can be reduced up to 60%, that would be around 10 USD per shipment. They’ve stated the business has the potential to reduce the industry’s expenses here by up to 3 billion USD. Fairly impressive right. What’s even more exciting is since 2016 has already conducted several pilot programs with off-the-shelf tech, recorded over 10K datapoints and have close contracts with a $5+ billion revenue company. The whitepaper is clearly states the Modum system is being integrated with the leading last-mile logistics service provider in Switzerland, and three pilots completed. Announcements of partnerships with companies is now common in crypto, with developers working together, but this is a huge step in a company having blockchain tech adapted on such a large scale.
In the latest CEO update the first 200 prototype sensors have arrived, and mass-production of 10,000 has been set up. One of the issues brought up in the whitepaper from the first pilot was the need for quicker connectivity between the logger and mobile application, data transfer speed boosted, and a proper UI for data analysis created. This was addressed in the two further pilots, and the production of 10K sensors is an enormous investment by the company. Combined with the news of a contract signing, this is a strong message of confidence in the product from the customer and modum.
Modum’s prototype asset tracker was chosen by Canadian company Nordic Sensors as one of eight products for demonstration at the Consumer Technology Association, a huge technology conference held in LA. Variosystems was mentioned in a previous update as being involved in the production of the prototypes back in August. Modum on Dec 12. was announced as the latest member of the Trusted IoT alliance, the open source software consortium. So far the group consists of some huge names in technology, such as Bosch, Cisco, and UBS. Other recognizable names in crypto such as QTUM, vechain, IOTA and consensys are also members.
Alongside its announced partnerships, Modum’s physical location could also be an important factor to its future success. They are currently based in Zurich, near to Basel – European pharma hotspot. Novartis, Hoffmann-La Roche, Basilea Pharmaceutica, Straumann and Actelion have their HQs in Basel. Pascal Degen, the Head of Sterile Packaging at Novartis is also a member of the Modum team. Nearby is Zug, home to Crypto Valley which has KPMG as a strategic partner, and Crypto Valley Labs, where Blockchaingers, organizers of previous hackathons are based. From an academic perspective, partnerships with staff from University of Zurich and University of St. Gallen, such as Prof Burkhard Stiller (the communications chair at Zurich) and Prof Erik Hofmann (expert in strategic supply chain management and author of Supply Chain Finance and Blockchain Technology) all point towards a top-tier product based in reality.
What we can see here is a clear business model that concentrates on a specfic market, that also has potential for large and consistent revenue stream. The product is proven and has real backing across the pharma industry and academia. If you haven’t already I highly recommend you read the Modum Whitepaper.
Part 2 will contain token structure, performance in the market so far, concerns around its potential classification as a security and potential competitors in the cryptosphere and across the industry.
Part 2 is located here.